Positive End-Expiratory Pressure (PEEP) Levels During Resuscitation of Preterm Infants at Birth (The POLAR Trial).
Condition(s) studied
Investigational drug(s) / intervention(s)
Positive End-Expiratory Pressure (PEEP): PEEP is the delivery of any level of positive pressure to the lungs during expiration, by any method of assisted respiratory support. As the intervention in the Delivery Room PEEP will be administered via any of: 1. Continuous Positive Applied Pressure (CPAP; non-invasive respiratory support) During CPAP, no other type of positive pressure is delivered as the infant supports tidal ventilation using her/his own spontaneous breathing effort. 2. Positive Pressure Ventilation (PPV) During PPV, PEEP is delivered between periods of an applied inflating pressure (PIP) delivered at a clinician-determined rate. PPV can be delivered via a mask or other non-invasive interface (also termed non-invasive positive pressure ventilation; NIPPV), or via an endotracheal tube (often termed continuous mechanical ventilation; CMV).
Study summary
Premature babies often need help immediately after birth to open their lungs to air, start breathing and keep their hearts beating. Opening their lungs can be difficult, and once open the under-developed lungs of premature babies will often collapse again between each breath. To prevent this nearly all premature babies receive some form of mechanical respiratory support to aid breathing. Common to all types of respiratory support is the delivery of a treatment called positive end-expiratory pressure, or PEEP. PEEP gives air, or a mixture of air and oxygen, to the lung between each breath to keep the lungs open and stop them collapsing.
Currently, clinicians do not have enough evidence on the right amount, or level, of PEEP to give at birth. As a result, doctors around the world give different amounts (or levels) of PEEP to premature babies at birth.
In this study, the Investigators will look at 2 different approaches to PEEP to help premature babies during their first breaths at birth. At the moment, the Investigators do not know if one is better than the other. One is to give the same PEEP level to the lungs. The others is to give a high PEEP level at birth when the lungs are hardest to open and then decrease the PEEP later once the lungs are opened and the baby is breathing.
Very premature babies have a risk of long-term lung disease (chronic lung disease). The more breathing support a premature baby needs, the more likely the risk of developing chronic lung disease. The Investigators want to find out whether one method of opening the baby's lungs at birth results in them needing less breathing support.
This research has been initiated by a group of doctors from Australia, the Netherlands and the USA, all who look after premature babies.
Eligibility
Primary outcome measure(s)
- The prevalence of the composite outcome of either death or bronchopulmonary dysplasia (BPD), as assessed by standard oxygen reduction test. — At 36 weeks post menstrual age.
This is defined as the proportion of participants in the analysis set with a confirmed death date or a diagnosis of bronchopulmonary dysplasia (BPD), at 36 weeks post menstrual age.
Trial sites (27)
| Facility | City | Region | Status |
|---|---|---|---|
| University of Arkansas for Medical Sciences | Little Rock | Arkansas | |
| Sharp Mary Birch Hospital for Women & Newborns | San Diego | California | |
| Indiana University / Riley Children Health at Indiana University Health | Indianapolis | Indiana | |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | |
| Mater Misericordiae | South Brisbane | Queensland | |
| Women & Childrens Hospital Adelaide | Adelaide | South Australia | |
| Joan Kirner Women & Children's Hospital - VIC | Melbourne | Victoria | |
| The Royal Women's Hospital, Melbourne Australia | Parkville | Victoria | |
| King Edward Memorial Hospital | Subiaco | Western Australia | |
| Academic Teaching Hospital | Feldkirch | Austria | |
| Antoine Beclere Medical Center / South Paris University Hospitals | Paris | France | |
| San Gerardo Hospital | Monza | Milan | |
| Filippo del Ponte Hospital | Varese | Milan | |
| Careggi Hospital | Florence | Italy | |
| Ospedale Maggiore Policlinico | Milan | Italy | |
| Vittore Buzzi Children's Hospital / Ospedale dei Bambini | Milan | Italy | |
| Gemelli University Hospital | Rome | Italy | |
| Amsterdam University Medical Centre | Amsterdam | Netherlands | |
| Amalia Children's Hospital Radboudumc | Nijmegen | Netherlands | |
| Maxima Medical Centre | Veldhoven | Netherlands | |
| Birmingham Heartlands Hospital | Birmingham | England | |
| Southmead Hospital | Bristol | England | |
| James Cook University Hospital | Middlesbrough | England | |
| Royal Infirmary Edinburgh | Edinburgh | Scotland | |
| Royal Hospital for Children | Glasgow | Scotland | |
| University Hospital Wishaw | Wishaw | Scotland | |
| University Hospitals Leicester | Leicester | United Kingdom |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04372953 on ClinicalTrials.gov ↗ ← All trials in France